Compliance Rate
Compliance Rate
66.67%
Compliant submissions
2
Incompliant submissions
1
Total trials
3
My Organizations' Clinical Trials
Showing 300 of 458 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/15/20
End: 09/13/21
Due: 09/13/22
Phase: N/A
Priority: Normal
Start: 08/15/16
End: 04/28/20
Due: 04/28/21
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 11/25/15
Due: 11/25/16
Phase: N/A
Priority: Normal
Start: 01/31/98
End: 11/17/08
Due: 11/17/09
Phase: N/A
Priority: Normal
Start: 03/01/07
End: 12/30/27
Due: 12/30/28
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 05/31/07
Due: 05/31/08
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 07/20/17
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 06/28/22
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 08/13/21
End: 03/09/24
Due: 03/09/25
Phase: N/A
Priority: Normal
Start: 02/29/00
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 12/18/14
End: 01/18/17
Due: 01/18/18
Phase: N/A
Priority: Normal
Start: 10/07/19
End: 04/15/21
Due: 04/15/22
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 05/12/22
End: 10/21/24
Due: 10/21/25
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 11/08/23
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 02/11/22
End: 12/13/22
Due: 12/13/23
Phase: N/A
Priority: Normal
Start: 02/13/23
End: 02/28/24
Due: 02/28/25